Brentuximab vedotin in combination with chemotherapy for pediatric patients with ALK+ ALCL: results of COG trial ANHL12P1. Lowe EJ, Reilly AF, Lim MS, Gross TG, et al. Blood 2021;137:3595-3603.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lowe EJ, Reilly AF, Lim MS, Gross TG, et al. Brentuximab vedotin in combination with chemotherapy for pediatric patients with ALK+ ALCL: results of COG trial ANHL12P1. Blood 2021;137:3595-3603.
PMID: 33684925